Furthermore, CD40-treated Gpr183−/−Rag1−/− mice developed only mild colitis with an inflammation score similar to that of PBS-treated Gpr183+/+Rag1−/− mice (Figure 7F). This evidence concerns the gene GPR183 and colitis.